Riskpilot← Back to searchSign inGet full accessGentian Diagnostics AB
ABActiveOrg 5590383302Kungsgatan 8Research and experimental development on natural sciences and engineering · NACE 7210Est. 20151-4 employees
Revenue 2024
SEK 22,6M
+5% vs 2023
EBITDA margin
-6.7%
-2% vs 2023
Equity ratio
8.2%
Financial strength
Net profit 2024
SEK -1,7M
-3% vs 2023
| Revenue | SEK 22,6M | +5% |
| EBITDA | SEK -1,5M | -2% |
| Net profit | SEK -1,7M | -3% |
| Total assets | SEK 7,8M | +40% |
| Equity | SEK 639K | -50% |
| Employees | — | — |
Legal name
Gentian Diagnostics AB
Org number
5590383302
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
2 december 2015
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva tillverkning av antikroppar och andra biokemiska råvarukomponenter till medicinsk diagnostisk industri, och för övrigt forskning, utveckling, produktion och försäljning av diagnostiska produkter till hälsovården och därmed förenlig verksamhet.
Address
Kungsgatan 8
Email
aleksandra.havelka@gentian.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 9 667 | 10 736 | 15 098 | 21 604 | 22 581 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 353 | 111 | −1 227 | −1 492 | −1 522 |
| Depreciation & amort. | −72 | −77 | −92 | −92 | −89 |
| EBIT | 281 | 34 | −1 319 | −1 584 | −1 611 |
| Net financials | −11 | −82 | −67 | −59 | −89 |
| Profit before tax | 270 | −47 | −1 386 | −1 643 | −1 700 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 270 | −47 | −1 386 | −1 643 | −1 700 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 742 | 3 989 | 4 486 | 5 583 | 7 820 |
| Equity | 2 366 | 2 318 | 932 | 1 289 | 639 |
| Long-term debt | 0 | 0 | 0 | 0 | 2 751 |
| Short-term debt | 2 376 | 1 671 | 3 554 | 4 294 | 4 430 |
| Total debt | 2 376 | 1 671 | 3 554 | 4 294 | 7 181 |
EBITDA margin
-6.7%
This company
15.8%
Market median
-142% vs market
20202024
Equity ratio
8.2%
This company
38.2%
Market median
-79% vs market
20202024
Return on equity
-266.0%
This company
18.4%
Market median
-1546% vs market
20202024
Net profit margin
-7.5%
This company
8.1%
Market median
-193% vs market
20202024
Asset turnover
2.89×
This company
1.12×
Market median
+158% vs market
20202024
Debt / equity
11.24×
This company
0.62×
Market median
-1713% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AM Chief Executive Officer | Chief Executive Officer | 2021 |
BL Chief Auditor | Chief Auditor | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2021 – 2024 | |
| Chairman | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gentian Diagnostics AB 
Getica ABBoard members of Gentian Diagnostics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aleksandra Mandic Havelka | Chief Executive Officer | 0 companies |
| Barbro Linnéa Karlsson | Chief Auditor | 0 companies |
| Julie Alling Gryga | Deputy Board Member | 0 companies |
| Hilja Ibert | Chairman | 0 companies |
| Ole Kristian Sørlie | Deputy Board Member | 0 companies |
| Njaal Kind | Board of Directors | 0 companies |